David C. Hanley - Feb 28, 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role: CHIEF TECHNICAL OPERATIONS
Signature: /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol: NUVB
Transactions as of: Feb 28, 2025
Transactions value $: $0
Form type: 4
Date filed: 3/4/2025, 06:29 PM
Previous filing: Mar 4, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NUVB	Class A Common Stock						18K	Feb 28, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVB	Stock Option (Right to Buy)	Award	$0	+500K		$0.00	500K	Feb 28, 2025	Class A Common Stock	500K	$1.97	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 3,000 shares acquired on May 17, 2024 and 3,000 shares acquired on November 19, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.
F2	Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.